EISAI CO.,LTD
Corporate VCTokyo · Seed–Growth · 1 people tracked
Also known as エーザイ株式会社
Find your way into EISAI CO.,LTD
Sign up to see every warm intro you have to EISAI CO.,LTD
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EISAI CO.,LTD team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Eisai is a global pharmaceutical company built around its human health care (hhc) corporate philosophy, focused on developing treatments in neurology and oncology and addressing neglected tropical diseases.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 1 of 1 portfolio companiesAI & Machine Learning ×1Data & Infrastructure ×1Digital Health ×1Healthtech ×1Longevity ×1SaaS ×1
HQs:Japan×1
Investments · 1 tracked
founders shown can be your intro pathRehab for JAPAN develops and provides "Rehab Cloud," a SaaS platform for elderly care and rehabilitation providers, along with "Rehab Studio," an online rehabilitation service, and conducts R&D on AI-based care technology.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechLongevitySaaSTokyo, JP
大久保亮(代表取締役社長 CEO)in
Co-investorsCapital Medica VenturesMitsubishi UFJ CapitalMonex VenturesMTG VenturesNissay CapitalOmron Ventures+5 more
Frequently asked questions
- What stage does EISAI CO.,LTD invest at?
- EISAI CO.,LTD invests at the Seed, Series A, Growth stages.
- What sectors does EISAI CO.,LTD focus on?
- EISAI CO.,LTD focuses on Biotech, Healthtech, Sector Agnostic.
- Where is EISAI CO.,LTD located?
- EISAI CO.,LTD is headquartered in Tokyo, JP.
Images
Similar investors
Roche Venture Fund is the corporate venture arm of Roche, investing in life science companies across pharmaceuticals, diagnostics and digital health to foster innovation and generate financial returns.
iGlobe Partners is a Singapore-based venture capital firm, active since 1999, that invests in and helps scale early- and growth-stage technology startups into global leaders.
Tal Ventures is an Israel-based venture capital group with strong ties to the Israeli high-tech ecosystem, backing startups led by experienced founders whose technologies can make a difference.
Hiroshima Venture Capital Co. Ltd. is a Japanese venture capital firm that invests in and supports startups.
DC Investment Partners is a private fund that invests in early and growth stage companies with strong leadership, market traction, and a competitive edge, offering both capital and operational resources.



